VAS203

· veriNOS operations GmbH

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for VAS203, covering 2016-03-07 to 2019-08-09. Get the full timeline:

Most recent: Clinical Trial Update: Effects of the NO-synthase Inhibitor VAS203 on Renal Function in Healthy Volunteers [Phase 1]